Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
Page 2

The organizers of the program reckon that through the leveraging of the strengths, the pace of grant-funded medications development for SUDs will be substantially accelerated. As a result, the organizers encourage the proposals to be submitted under this program to focus at any point along the drug development continuum.

The initiative is also inspired by the fact that there is presently no FDA-approved medications for the treatment of cocaine, methamphetamine, or cannabis use disorders. To this regard, the NIH and NIDA hope that the results of the program will accelerate medication development, foster collaborative ventures between entities such that each offers financial resources, in-kind resources, and/or expertise toward the development of safe and effective medications for SUDs.

To support this program, the NIH and NIDA are willing to administer funds in the amount of $2,000,000 per year for a project that could last for up to 3 years.

The institutions and organizations who will be deemed eligible to take part in the program are the following:

a) Higher Education Institutions such as Public and Private Institutions of Higher Education

b) Nonprofit Organizations

c) For-profit Organizations Such as Small Businesses

d) State Governments, County Governments, City or Township Governments, Special District Governments, and Indian/Native American Tribal Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations, and Faith-based or Community-based Organizations

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on children grants and education grant money.

Additional Resources

category - Health Grants

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities
The National Institutes of Health has recently formed a partnership with the National Cancer Institute (NCI) in an effort to constitute the Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities wherein both agencies intend to solicit grant application from various eligible researchers who are interested in conducing basic research studies regarding the biological causes and mechanisms of cancer health disparities.

---